AMBER LADNER: Open Payments
NPI 1659003580 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,830 in 134 payments from 27 companies in 2025. Trend: 2023 $3,069 · 2024 $2,685 · 2025 $3,830
Food & beverage: $2,552Travel & lodging: $1,246Education: $33
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $1,793 |
| ABBVIE INC. | 23 | $405 |
| UCB, Inc. | 17 | $305 |
| PFIZER INC. | 22 | $212 |
| Lilly USA, LLC | 11 | $138 |
| EMD Serono, Inc. | 8 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Amgen Inc. | 3 | $73 |
| Eisai Inc. | 4 | $72 |
Products named: PROCLAIM, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, BOTOX, Fintepla, NURTEC ODT, ETERNA, QULIPTA, AMYVID.
Industry payments across MS — which companies pay providers there.
